HEADER HYDROLASE/HYDROLASE INHIBITOR 17-JAN-99 1B6J
TITLE HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 1
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: RETROPEPSIN;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: HIV-1 PR;
COMPND 5 EC: 3.4.23.16;
COMPND 6 MUTATION: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: CYCLIC PEPTIDE INHIBITOR;
COMPND 9 CHAIN: C;
COMPND 10 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 3 ORGANISM_TAXID: 11676;
SOURCE 4 OTHER_DETAILS: CYS RESIDUES REPLACED WITH ABA;
SOURCE 5 MOL_ID: 2;
SOURCE 6 SYNTHETIC: YES
KEYWDS COMPLEX (ACID PROTEINASE-PEPTIDE), HYDROLASE-HYDROLASE INHIBITOR
KEYWDS 2 COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.L.MARTIN,J.BEGUN,A.SCHINDELER,W.A.WICKRAMASINGHE,D.ALEWOOD,
AUTHOR 2 P.F.ALEWOOD,D.A.BERGMAN,R.I.BRINKWORTH,G.ABBENANTE,D.R.MARCH,
AUTHOR 3 R.C.REID,D.P.FAIRLIE
REVDAT 6 15-NOV-23 1B6J 1 LINK
REVDAT 5 09-AUG-23 1B6J 1 REMARK LINK
REVDAT 4 13-MAR-13 1B6J 1 ATOM HET HETATM REMARK
REVDAT 4 2 1 VERSN
REVDAT 3 24-FEB-09 1B6J 1 VERSN
REVDAT 2 01-APR-03 1B6J 1 JRNL
REVDAT 1 07-JAN-00 1B6J 0
JRNL AUTH J.L.MARTIN,J.BEGUN,A.SCHINDELER,W.A.WICKRAMASINGHE,
JRNL AUTH 2 D.ALEWOOD,P.F.ALEWOOD,D.A.BERGMAN,R.I.BRINKWORTH,
JRNL AUTH 3 G.ABBENANTE,D.R.MARCH,R.C.REID,D.P.FAIRLIE
JRNL TITL MOLECULAR RECOGNITION OF MACROCYCLIC PEPTIDOMIMETIC
JRNL TITL 2 INHIBITORS BY HIV-1 PROTEASE.
JRNL REF BIOCHEMISTRY V. 38 7978 1999
JRNL REFN ISSN 0006-2960
JRNL PMID 10387041
JRNL DOI 10.1021/BI990174X
REMARK 2
REMARK 2 RESOLUTION. 1.85 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.851
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.1
REMARK 3 NUMBER OF REFLECTIONS : 14540
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.175
REMARK 3 FREE R VALUE : 0.219
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100
REMARK 3 FREE R VALUE TEST SET COUNT : 1474
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.96
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 54.70
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1310
REMARK 3 BIN R VALUE (WORKING SET) : 0.2310
REMARK 3 BIN FREE R VALUE : 0.2460
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1541
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 15
REMARK 3 SOLVENT ATOMS : 120
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 8.40
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.40
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.00000
REMARK 3 B22 (A**2) : 0.00000
REMARK 3 B33 (A**2) : 0.00000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18
REMARK 3 ESD FROM SIGMAA (A) : 0.18
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.006
REMARK 3 BOND ANGLES (DEGREES) : 1.400
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.10
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.480
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.250 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.010 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 2.240 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.760 ; 2.500
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PARHCSDXJABB
REMARK 3 PARAMETER FILE 2 : PARAM19.SOL
REMARK 3 PARAMETER FILE 3 : NULL
REMARK 3 PARAMETER FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 1 : TOPHCSDXJABB.PRO
REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL
REMARK 3 TOPOLOGY FILE 3 : INHIBTOP.INP
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1B6J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JAN-99.
REMARK 100 THE DEPOSITION ID IS D_1000000308.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 01-DEC-93
REMARK 200 TEMPERATURE (KELVIN) : 289
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : GRAPHITE
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14847
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 89.0
REMARK 200 DATA REDUNDANCY : 5.700
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.06600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92
REMARK 200 COMPLETENESS FOR SHELL (%) : 50.0
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.23000
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.900
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: PDB ENTRY 7HVP
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 43.31
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M ACETATE BUFFER PH 5.5 AND 30-60%
REMARK 280 AMMONIUM SULFATE
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.61500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.09500
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.34500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.09500
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.61500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.34500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5720 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9090 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400
REMARK 400 THE 1-{(2R)-2-[(8R,11S)-8-(2-AMINO-2-OXOETHYL)-6,9-DIOXO-2-OXA-7,10-
REMARK 400 DIAZABICYCLO[11.2.2]HEPTADECA-1(15),13,16-TRIEN-11-YL]-2-
REMARK 400 HYDROXYETHYL}-L-PROLYL-L-ISOLEUCYL-L-VALINAMIDE IS PEPTIDE-LIKE, A
REMARK 400 MEMBER OF INHIBITOR CLASS.
REMARK 400
REMARK 400 GROUP: 1
REMARK 400 NAME: 1-{(2R)-2-[(8R,11S)-8-(2-AMINO-2-OXOETHYL)-6,9-DIOXO-2-OXA-
REMARK 400 7,10-DIAZABICYCLO[11.2.2]HEPTADECA-1(15),13,16-TRIEN-11-YL]-
REMARK 400 2-HYDROXYETHYL}-L-PROLYL-L-ISOLEUCYL-L-VALINAMIDE
REMARK 400 CHAIN: C
REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER
REMARK 400 DESCRIPTION: NULL
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 41 CG CD CE NZ
REMARK 470 LYS A 43 CG CD CE NZ
REMARK 470 LYS A 45 CG CD CE NZ
REMARK 470 LYS A 70 CG CD CE NZ
REMARK 470 LYS B 141 CG CD CE NZ
REMARK 470 LYS B 143 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 79 86.30 -69.53
REMARK 500 GLU B 135 125.46 -37.93
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 101
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 102
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF CYCLIC PEPTIDE
REMARK 800 INHIBITOR
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1B6K RELATED DB: PDB
REMARK 900 HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 5
REMARK 900 RELATED ID: 1B6L RELATED DB: PDB
REMARK 900 HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 4
REMARK 900 RELATED ID: 1B6M RELATED DB: PDB
REMARK 900 HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 6
REMARK 900 RELATED ID: 1B6N RELATED DB: PDB
REMARK 900 HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 3
REMARK 900 RELATED ID: 1B6O RELATED DB: PDB
REMARK 900 HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 2
REMARK 900 RELATED ID: 1B6P RELATED DB: PDB
REMARK 900 HIV-1 PROTEASE COMPLEXED WITH MACROCYCLIC PEPTIDOMIMETIC INHIBITOR 7
DBREF 1B6J A 1 99 UNP P03369 POL_HV1A2 57 155
DBREF 1B6J B 101 199 UNP P03369 POL_HV1A2 57 155
DBREF 1B6J C 1 6 PDB 1B6J 1B6J 1 6
SEQADV 1B6J ABA A 67 UNP P03369 CYS 123 SEE REMARK 999
SEQADV 1B6J ABA A 95 UNP P03369 CYS 151 SEE REMARK 999
SEQADV 1B6J ABA B 167 UNP P03369 CYS 123 SEE REMARK 999
SEQADV 1B6J ABA B 195 UNP P03369 CYS 151 SEE REMARK 999
SEQADV 1B6J LYS A 41 UNP P03369 LYS 97 SEE REMARK 999
SEQADV 1B6J LYS A 43 UNP P03369 LYS 99 SEE REMARK 999
SEQADV 1B6J LYS A 45 UNP P03369 LYS 101 SEE REMARK 999
SEQADV 1B6J LYS A 70 UNP P03369 LYS 126 SEE REMARK 999
SEQADV 1B6J LYS B 141 UNP P03369 LYS 97 SEE REMARK 999
SEQADV 1B6J LYS B 143 UNP P03369 LYS 99 SEE REMARK 999
SEQRES 1 A 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE
SEQRES 2 A 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 A 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO
SEQRES 4 A 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU
SEQRES 6 A 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 A 99 GLN ILE GLY ABA THR LEU ASN PHE
SEQRES 1 B 99 PRO GLN ILE THR LEU TRP GLN ARG PRO LEU VAL THR ILE
SEQRES 2 B 99 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 B 99 GLY ALA ASP ASP THR VAL LEU GLU GLU MET ASN LEU PRO
SEQRES 4 B 99 GLY LYS TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU
SEQRES 6 B 99 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 B 99 GLN ILE GLY ABA THR LEU ASN PHE
SEQRES 1 C 6 ASN RTY PRO ILE VAL NH2
MODRES 1B6J ABA A 67 ALA ALPHA-AMINOBUTYRIC ACID
MODRES 1B6J ABA A 95 ALA ALPHA-AMINOBUTYRIC ACID
MODRES 1B6J ABA B 167 ALA ALPHA-AMINOBUTYRIC ACID
MODRES 1B6J ABA B 195 ALA ALPHA-AMINOBUTYRIC ACID
HET ABA A 67 6
HET ABA A 95 6
HET ABA B 167 6
HET ABA B 195 6
HET RTY C 2 18
HET NH2 C 6 1
HET SO4 A 101 5
HET SO4 A 102 5
HET SO4 B 501 5
HETNAM ABA ALPHA-AMINOBUTYRIC ACID
HETNAM RTY 4-{4-[(2S,3R)-2-AMINO-4-BROMO-3-
HETNAM 2 RTY HYDROXYBUTYL]PHENOXY}BUTANOIC ACID
HETNAM NH2 AMINO GROUP
HETNAM SO4 SULFATE ION
FORMUL 1 ABA 4(C4 H9 N O2)
FORMUL 3 RTY C14 H20 BR N O4
FORMUL 3 NH2 H2 N
FORMUL 4 SO4 3(O4 S 2-)
FORMUL 7 HOH *120(H2 O)
HELIX 1 1 GLY A 86 THR A 91 1 6
HELIX 2 2 GLY B 186 THR B 191 1 6
HELIX 3 3 GLN B 192 GLY B 194 5 3
SHEET 1 A 4 GLN A 2 THR A 4 0
SHEET 2 A 4 THR B 196 ASN B 198 -1 O LEU B 197 N ILE A 3
SHEET 3 A 4 THR A 96 ASN A 98 -1 O THR A 96 N ASN B 198
SHEET 4 A 4 GLN B 102 THR B 104 -1 N ILE B 103 O LEU A 97
LINK C ILE A 66 N ABA A 67 1555 1555 1.33
LINK C ABA A 67 N GLY A 68 1555 1555 1.33
LINK C GLY A 94 N ABA A 95 1555 1555 1.33
LINK C ABA A 95 N THR A 96 1555 1555 1.33
LINK C ILE B 166 N ABA B 167 1555 1555 1.33
LINK C ABA B 167 N GLY B 168 1555 1555 1.33
LINK C GLY B 194 N ABA B 195 1555 1555 1.33
LINK C ABA B 195 N THR B 196 1555 1555 1.33
LINK C ASN C 1 N RTY C 2 1555 1555 1.33
LINK N ASN C 1 C2 RTY C 2 1555 1555 1.33
LINK C6 RTY C 2 N PRO C 3 1555 1555 1.47
LINK C VAL C 5 N NH2 C 6 1555 1555 1.33
SITE 1 AC1 5 PRO A 1 ARG A 57 HIS A 69 HOH A 213
SITE 2 AC1 5 HOH A 254
SITE 1 AC2 6 ARG A 14 ARG B 114 GLY B 116 GLY B 117
SITE 2 AC2 6 HOH B 614 HOH B 633
SITE 1 AC3 6 GLY A 68 HIS A 69 LYS A 70 HOH A 244
SITE 2 AC3 6 PRO B 101 LYS B 155
SITE 1 AC4 21 ARG A 8 ASP A 25 GLY A 27 ALA A 28
SITE 2 AC4 21 ASP A 29 ASP A 30 GLY A 48 GLY A 49
SITE 3 AC4 21 ILE A 50 PRO A 81 HOH A 228 ARG B 108
SITE 4 AC4 21 ASP B 125 GLY B 127 ALA B 128 ASP B 129
SITE 5 AC4 21 ILE B 147 GLY B 148 GLY B 149 VAL B 182
SITE 6 AC4 21 HOH C 301
CRYST1 51.230 58.690 62.190 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019520 0.000000 0.000000 0.00000
SCALE2 0.000000 0.017039 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016080 0.00000